Table of Contents
About This Report Datamonitor surveyed 108 rheumatologists in the US in the wake of Benlysta’s approval, gauging current perceptions of the drug and the clinical impact that it will have. Lessons learned from the clinical trial program of Benlysta are already being applied to additional drug candidates, and large-scale international trials are becoming the norm. What's Included in This Report? Access Datamo...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Jordan
+1 917 267 7886
PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) - diabetic nephropathy, ...
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked ...
Product Synopsis Disease-related, demographic, and desire-led drivers are making health of growing importance to food marketers. However, barriers such as cost, habits, and confusion over how to eat healthily ...
... New congenital heart disease review what matters a commitment to research ensures that services are continually focussed on improvement and development, so networks will be required to have ...
... Conditions back pain musculoskeletal injuries stress minor illnesses the most common causes of short-term absence in non-manual workers (%) source bupa jan 2013 absence statistics 0 20 40 60 80 100 ...
Reportlinker.com © Copyright 2014. All rights reserved.